Special article
Security profile of direct anticoagulants. Preferred use in atrial fibrillation
Perfil de seguridad de los anticoagulantes directos. Uso preferente en fibrilación auricular
Inmaculada Roldán Rabadána, María Alonso de Leciñanab, Raquel Barba Martínc, José Antonio Páramo Fernándezd,
, the Cardiovascular Thrombosis Forum ◊
Corresponding author
a Servicio Cardiología, Hospital Universitario La Paz, CIBER-CV, Madrid, Spain
b Servicio Neurología, Hospital Universitario La Paz, Madrid, Spain
c Servicio de Medicina Interna, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain
d Servicio de Hematología, Clínica Universidad de Navarra, CIBER-CV, Pamplona, Spain
Read
1340
Timeswas read the article
374
Total PDF
966
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 39 | 17 | 56 |
| 2025 11 | 93 | 68 | 161 |
| 2025 10 | 21 | 26 | 47 |
| 2025 9 | 28 | 17 | 45 |
| 2025 8 | 33 | 10 | 43 |
| 2025 7 | 39 | 17 | 56 |
| 2025 6 | 30 | 4 | 34 |
| 2025 5 | 40 | 7 | 47 |
| 2025 4 | 38 | 4 | 42 |
| 2025 3 | 34 | 15 | 49 |
| 2025 2 | 33 | 4 | 37 |
| 2025 1 | 20 | 1 | 21 |
| 2024 12 | 25 | 4 | 29 |
| 2024 11 | 21 | 8 | 29 |
| 2024 10 | 5 | 12 | 17 |
| 2024 9 | 42 | 6 | 48 |
| 2024 8 | 13 | 9 | 22 |
| 2024 7 | 10 | 4 | 14 |
| 2024 6 | 18 | 5 | 23 |
| 2024 5 | 28 | 12 | 40 |
| 2024 4 | 24 | 8 | 32 |
| 2024 3 | 12 | 5 | 17 |
| 2024 2 | 4 | 1 | 5 |
| 2024 1 | 31 | 3 | 34 |
| 2023 12 | 15 | 3 | 18 |
| 2023 11 | 8 | 8 | 16 |
| 2023 10 | 7 | 7 | 14 |
| 2023 9 | 6 | 1 | 7 |
| 2023 8 | 8 | 3 | 11 |
| 2023 7 | 7 | 7 | 14 |
| 2023 6 | 18 | 2 | 20 |
| 2023 5 | 37 | 4 | 41 |
| 2023 4 | 29 | 0 | 29 |
| 2023 3 | 33 | 0 | 33 |
| 2023 2 | 5 | 1 | 6 |
| 2023 1 | 10 | 8 | 18 |
| 2022 12 | 10 | 4 | 14 |
| 2022 11 | 9 | 3 | 12 |
| 2022 10 | 12 | 4 | 16 |
| 2022 9 | 15 | 7 | 22 |
| 2022 8 | 10 | 8 | 18 |
| 2022 7 | 9 | 5 | 14 |
| 2022 6 | 8 | 7 | 15 |
| 2022 5 | 8 | 5 | 13 |
| 2022 4 | 5 | 9 | 14 |
| 2022 3 | 9 | 11 | 20 |
| 2022 2 | 7 | 0 | 7 |
Show all